Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016, Article ID 6729379, 11 pages
http://dx.doi.org/10.1155/2016/6729379
Research Article

Association of Immunosuppression with DR6 Expression during the Development and Progression of Spontaneous Ovarian Cancer in Laying Hen Model

1Rush University Medical Center, Chicago, IL 60612, USA
2University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA
3University of Chicago, Chicago, IL 60637, USA

Received 2 June 2016; Accepted 10 July 2016

Academic Editor: Anil Shanker

Copyright © 2016 Sa’Rah McNeal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, J. Ma, Z. Zou, and A. Jemal, “Cancer statistics, 2014,” CA Cancer Journal for Clinicians, vol. 64, no. 1, pp. 9–29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. L. A. G. Ries, “Ovarian cancer: survival and treatment differences by age,” Cancer, vol. 71, no. 2, pp. 524–529, 1993. View at Google Scholar · View at Scopus
  3. M. T. Goodman, C. N. Correa, K.-H. Tung et al., “Stage at diagnosis of ovarian cancer in the United States, 1992–1997,” Cancer, vol. 97, no. 10, supplement, pp. 2648–2659, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Yigit, L. F. A. G. Massuger, C. G. Figdor, and R. Torensma, “Ovarian cancer creates a suppressive microenvironment to escape immune elimination,” Gynecologic Oncology, vol. 117, no. 2, pp. 366–372, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. R. M. Locksley, N. Killeen, and M. J. Lenardo, “The TNF and TNF receptor superfamilies: integrating mammalian biology,” Cell, vol. 104, no. 4, pp. 487–501, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Pan, J. H. Bauer, V. Haridas et al., “Identification and functional characterization of DR6, a novel death domain-containing TNF receptor,” FEBS Letters, vol. 431, no. 3, pp. 351–356, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. G. M. Kasof, J. J. Lu, D. Liu et al., “Tumor necrosis factor-α induces the expression of DR6, a member of the TNF receptor family, through activation of NF-κB,” Oncogene, vol. 20, no. 55, pp. 7965–7975, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. D. C. DeRosa, P. J. Ryan, A. Okragly, D. R. Witcher, and R. J. Benschop, “Tumor-derived death receptor 6 modulates dendritic cell development,” Cancer Immunology, Immunotherapy, vol. 57, no. 6, pp. 777–787, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. R. M. Steinman and M. C. Nussenzweig, “Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 1, pp. 351–358, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Benschop, T. Wei, and S. Na, “Tumor necrosis factor receptor superfamily member 21: TNFR-related death receptor-6, DR6,” in Therapeutic Targets of the TNF Superfamily, I. S. Grewal, Ed., vol. 647, pp. 186–194, Landes Bioscience, Austin, Tex, USA, 2009, http://www.landesbioscience.com/books/1137/. View at Google Scholar
  11. D. Sasaroli, P. A. Gimotty, H. B. Pathak et al., “Novel surface targets and serum biomarkers from the ovarian cancer vasculature,” Cancer Biology and Therapy, vol. 12, no. 3, pp. 169–180, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. R. J. Buckanovich, D. Sasaroli, A. O'Brien-Jenkins et al., “Tumor vascular proteins as biomarkers in ovarian cancer,” Journal of Clinical Oncology, vol. 25, no. 7, pp. 852–861, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Barua, P. Bitterman, J. S. Abramowicz et al., “Histopathology of ovarian tumors in laying hens a preclinical model of human ovarian cancer,” International Journal of Gynecological Cancer, vol. 19, no. 4, pp. 531–539, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. P. A. Johnson and J. R. Giles, “The hen as a model of ovarian cancer,” Nature Reviews Cancer, vol. 13, no. 6, pp. 432–436, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. T. N. Fredrickson, “Ovarian tumors of the hen,” Environmental Health Perspectives, vol. 73, pp. 35–51, 1987. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Stammer, S. L. Edassery, A. Barua et al., “Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer,” Gynecologic Oncology, vol. 109, no. 1, pp. 115–121, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. A. A. Hakim, C. P. Barry, H. J. Barnes et al., “Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu,” Cancer Prevention Research, vol. 2, no. 2, pp. 114–121, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Barua, A. Yellapa, J. M. Bahr et al., “Expression of death receptor 6 by ovarian tumors in laying hens, a preclinical model of spontaneous ovarian cancer,” Translational Oncology, vol. 5, no. 4, pp. 260–268, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. G. F. Erf, “Cell-mediated immunity in poultry,” Poultry Science, vol. 83, no. 4, pp. 580–590, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Barua, J. S. Abramowicz, J. M. Bahr et al., “Detection of ovarian tumors in chicken by sonography: a step toward early diagnosis in humans?” Journal of Ultrasound in Medicine, vol. 26, no. 7, pp. 909–919, 2007. View at Google Scholar · View at Scopus
  21. A. Barua, S. L. Edassery, P. Bitterman et al., “Prevalence of antitumor antibodies in laying hen model of human ovarian cancer,” International Journal of Gynecological Cancer, vol. 19, no. 4, pp. 500–507, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Barua, P. Bitterman, J. M. Bahr et al., “Detection of tumor-associated neoangiogenesis by doppler ultrasonography during early-stage ovarian cancer in laying hens: a preclinical model of human spontaneous ovarian cancer,” Journal of Ultrasound in Medicine, vol. 29, no. 2, pp. 173–182, 2010. View at Google Scholar · View at Scopus
  23. J. R. Giles, L. M. Olson, and P. A. Johnson, “Characterization of ovarian surface epithelial cells from the hen: a unique model for ovarian cancer,” Experimental Biology and Medicine, vol. 231, no. 11, pp. 1718–1725, 2006. View at Google Scholar · View at Scopus
  24. A. Barua, A. Yellapa, S. A. Grasso et al., “Expression of glucose-regulated protein 78 (GRP78) and its regulator microrna-181 during the development and progression of ovarian cancer,” Journal of Clinical Oncology, vol. 31, supplement, abstract 5579, 2013, Proceedings of the 2013 ASCO Annual Meeting. View at Google Scholar
  25. A. Barua and Y. Yoshimura, “Effects of aging and sex steroids on the localization of T cell subsets in the ovary of chicken, Gallus domesticus,” General and Comparative Endocrinology, vol. 114, no. 1, pp. 28–35, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Barua and Y. Yoshimura, “Ovarian cell-mediated immune response to Salmonella enteritidis infection in laying hens (Gallus domesticus),” Poultry Science, vol. 83, no. 6, pp. 997–1002, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. M. F. Khan, A. Yellapa, J. M. Bahr et al., “Expression of immunosuppressive leukocyte inhibitory Immunoglobulin like transcript 3 (ILT3) receptors increases with the development of and progression of ovarian tumors,” Translational Oncology, vol. 5, no. 2, pp. 85–91, 2012. View at Publisher · View at Google Scholar
  28. A. Barua, P. Bitterman, J. M. Bahr et al., “Contrast-enhanced sonography depicts spontaneous ovarian cancer at early stages in a preclinical animal model,” Journal of Ultrasound in Medicine, vol. 30, no. 3, pp. 333–345, 2011. View at Google Scholar · View at Scopus
  29. A. Barua, Y. Yoshimura, and T. Tamura, “Effects of ageing and oestrogen on the localization of immunoglobulin-containing cells in the chicken ovary,” Journal of Reproduction and Fertility, vol. 114, no. 1, pp. 11–16, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. H. Hong, H. S. Lillehoj, S. H. Lee, R. A. Dalloul, and E. P. Lillehoj, “Analysis of chicken cytokine and chemokine gene expression following Eimeria acervulina and Eimeria tenella infections,” Veterinary Immunology and Immunopathology, vol. 114, no. 3-4, pp. 209–223, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. J. T. Bridgham, J. Bobe, F. W. Goetz, and A. L. Johnson, “Conservation of death receptor-6 in avian and piscine vertebrates,” Biochemical and Biophysical Research Communications, vol. 284, no. 5, pp. 1109–1115, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. J. L. Luborsky, A. Barua, S. V. Shatavi, T. Kebede, J. Abramowicz, and J. Rotmensch, “Anti-tumor antibodies in ovarian cancer,” American Journal of Reproductive Immunology, vol. 54, no. 2, pp. 55–62, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. L. E. Kandalaft, N. Singh, J. B. Liao et al., “The emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decade,” Gynecologic Oncology, vol. 116, no. 2, pp. 222–233, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Degrandi, R. Hoffmann, C. Beuter-Gunia, and K. Pfeffer, “The proinflammatory cytokine-induced IRG1 protein associates with mitochondria,” Journal of Interferon and Cytokine Research, vol. 29, no. 1, pp. 55–67, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Matulova, J. Rajova, L. Vlasatikova et al., “Characterization of chicken spleen transcriptome after infection with salmonella enterica serovar enteritidis,” PLoS ONE, vol. 7, no. 10, article e48101, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. Y.-P. Cheon, X. Xu, M. K. Bagchi, and I. C. Bagchi, “Immune-responsive gene 1 is a novel target of progesterone receptor and plays a critical role during implantation in the mouse,” Endocrinology, vol. 144, no. 12, pp. 5623–5630, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Li, Z. Gang, H. Yuling et al., “Different neurotropic pathogens elicit neurotoxic CCR9- or neurosupportive CXCR3-expressing microglia,” The Journal of Immunology, vol. 177, no. 6, pp. 3644–3656, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Li, P. Zhang, C. Wang et al., “Immune Responsive Gene 1 (IRG1) promotes endotoxin tolerance by increasing A20 expression in macrophages through reactive oxygen species,” The Journal of Biological Chemistry, vol. 288, no. 23, pp. 16225–16234, 2013. View at Publisher · View at Google Scholar · View at Scopus